长期补充牛磺酸可调节小鼠大脑线粒体的动态变化。

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Heresh Rezaei, Hong-Wei Wang, Weishun Tian, Jing Zhao, Asma Najibi, Socorro Retana-Márquez, Elahe Rafiei, Ayeh Rowhanirad, Samira Sabouri, Mohammadreza Kiafar, Rahil Fazlinezhad, Amir Mohammad Niknahad, Fatemeh Evazzadeh, Seyedeh Tayebeh Anousheh, Mohammad Mehdi Ommati, Hossein Niknahad, Reza Heidari
{"title":"长期补充牛磺酸可调节小鼠大脑线粒体的动态变化。","authors":"Heresh Rezaei, Hong-Wei Wang, Weishun Tian, Jing Zhao, Asma Najibi, Socorro Retana-Márquez, Elahe Rafiei, Ayeh Rowhanirad, Samira Sabouri, Mohammadreza Kiafar, Rahil Fazlinezhad, Amir Mohammad Niknahad, Fatemeh Evazzadeh, Seyedeh Tayebeh Anousheh, Mohammad Mehdi Ommati, Hossein Niknahad, Reza Heidari","doi":"10.1111/bcpt.14101","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Taurine (TAU) is the most abundant non-protein amino acid in the central nervous system (CNS). However, the molecular mechanism of TAU in the CNS is still poorly understood. Meanwhile, disruption in mitochondrial dynamics is evident in CNS disorders. This study aimed to investigate the effect of TAU on mitochondrial dynamics.</p><p><strong>Methods: </strong>TAU (0.25, 0.5 and 1% in drinking water) was administered to young mice for six months. Several memory/cognition parameters and indices of anxiety/depression were assessed. Meanwhile, various mitochondrial indices and the expression/activity of genes involved in mitochondrial biogenesis and dynamics (Akt, CREB, NRF1, TFAM, PGC-1α, Mfn1, Mfn2, UCP2, PINK1, OPA1, Drp1 and Fis1) were examined.</p><p><strong>Results: </strong>TAU significantly enhanced memory performance, suppressed anxiety and depression-like behaviour, increased mitochondrial biogenesis/dynamics and improved mitochondrial indices. It should be mentioned that there was no significant difference between different concentrations of TAU in changing most brain mitochondrial dynamic biomarkers in the current study.</p><p><strong>Conclusions: </strong>These findings offer more insights into the molecular mechanism for TAU's action in the CNS. However, there is a need for further research to confirm these effects in humans. Overall, this study suggests the potential application of TAU in various neurological disorders and the need for clinical studies on the effects of this amino acid in the brain.</p>","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-term taurine supplementation regulates brain mitochondrial dynamics in mice.\",\"authors\":\"Heresh Rezaei, Hong-Wei Wang, Weishun Tian, Jing Zhao, Asma Najibi, Socorro Retana-Márquez, Elahe Rafiei, Ayeh Rowhanirad, Samira Sabouri, Mohammadreza Kiafar, Rahil Fazlinezhad, Amir Mohammad Niknahad, Fatemeh Evazzadeh, Seyedeh Tayebeh Anousheh, Mohammad Mehdi Ommati, Hossein Niknahad, Reza Heidari\",\"doi\":\"10.1111/bcpt.14101\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Taurine (TAU) is the most abundant non-protein amino acid in the central nervous system (CNS). However, the molecular mechanism of TAU in the CNS is still poorly understood. Meanwhile, disruption in mitochondrial dynamics is evident in CNS disorders. This study aimed to investigate the effect of TAU on mitochondrial dynamics.</p><p><strong>Methods: </strong>TAU (0.25, 0.5 and 1% in drinking water) was administered to young mice for six months. Several memory/cognition parameters and indices of anxiety/depression were assessed. Meanwhile, various mitochondrial indices and the expression/activity of genes involved in mitochondrial biogenesis and dynamics (Akt, CREB, NRF1, TFAM, PGC-1α, Mfn1, Mfn2, UCP2, PINK1, OPA1, Drp1 and Fis1) were examined.</p><p><strong>Results: </strong>TAU significantly enhanced memory performance, suppressed anxiety and depression-like behaviour, increased mitochondrial biogenesis/dynamics and improved mitochondrial indices. It should be mentioned that there was no significant difference between different concentrations of TAU in changing most brain mitochondrial dynamic biomarkers in the current study.</p><p><strong>Conclusions: </strong>These findings offer more insights into the molecular mechanism for TAU's action in the CNS. However, there is a need for further research to confirm these effects in humans. Overall, this study suggests the potential application of TAU in various neurological disorders and the need for clinical studies on the effects of this amino acid in the brain.</p>\",\"PeriodicalId\":8733,\"journal\":{\"name\":\"Basic & Clinical Pharmacology & Toxicology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-11-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Basic & Clinical Pharmacology & Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/bcpt.14101\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bcpt.14101","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:牛磺酸(TAU)是中枢神经系统(CNS)中含量最高的非蛋白氨基酸。然而,人们对牛磺酸在中枢神经系统中的分子机制仍知之甚少。同时,线粒体动力学的破坏在中枢神经系统疾病中十分明显。本研究旨在探讨TAU对线粒体动力学的影响:方法:给幼年小鼠注射 TAU(0.25%、0.5% 和 1% 的饮用水),为期 6 个月。方法:给幼鼠注射 TAU(在饮用水中分别添加 0.25、0.5 和 1%)6 个月,评估其记忆/认知参数以及焦虑/抑郁指数。同时,还检测了各种线粒体指数以及参与线粒体生物生成和动力学的基因(Akt、CREB、NRF1、TFAM、PGC-1α、Mfn1、Mfn2、UCP2、PINK1、OPA1、Drp1和Fis1)的表达/活性:结果:TAU能明显提高记忆力,抑制焦虑和抑郁行为,增加线粒体生物生成/动力学,改善线粒体指数。值得一提的是,在本研究中,不同浓度的TAU在改变大多数脑线粒体动态生物标志物方面没有明显差异:这些研究结果为TAU在中枢神经系统中发挥作用的分子机制提供了更多见解。然而,还需要进一步的研究来证实这些作用对人体的影响。总之,这项研究表明 TAU 有可能应用于各种神经系统疾病,而且有必要对这种氨基酸在大脑中的作用进行临床研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Long-term taurine supplementation regulates brain mitochondrial dynamics in mice.

Background: Taurine (TAU) is the most abundant non-protein amino acid in the central nervous system (CNS). However, the molecular mechanism of TAU in the CNS is still poorly understood. Meanwhile, disruption in mitochondrial dynamics is evident in CNS disorders. This study aimed to investigate the effect of TAU on mitochondrial dynamics.

Methods: TAU (0.25, 0.5 and 1% in drinking water) was administered to young mice for six months. Several memory/cognition parameters and indices of anxiety/depression were assessed. Meanwhile, various mitochondrial indices and the expression/activity of genes involved in mitochondrial biogenesis and dynamics (Akt, CREB, NRF1, TFAM, PGC-1α, Mfn1, Mfn2, UCP2, PINK1, OPA1, Drp1 and Fis1) were examined.

Results: TAU significantly enhanced memory performance, suppressed anxiety and depression-like behaviour, increased mitochondrial biogenesis/dynamics and improved mitochondrial indices. It should be mentioned that there was no significant difference between different concentrations of TAU in changing most brain mitochondrial dynamic biomarkers in the current study.

Conclusions: These findings offer more insights into the molecular mechanism for TAU's action in the CNS. However, there is a need for further research to confirm these effects in humans. Overall, this study suggests the potential application of TAU in various neurological disorders and the need for clinical studies on the effects of this amino acid in the brain.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
6.50%
发文量
126
审稿时长
1 months
期刊介绍: Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信